Rocket Pharmaceuticals RCKT
NASDAQ RCKT
$2.56 -0.03 (-1.16%)
At close: Oct 2, 2026 · 4:00 PM EDT

Rocket Pharmaceuticals (RCKT) Cash from Investing Activities (2015 - 2026)

Updated

Rocket Pharmaceuticals (RCKT) recorded Cash from Investing Activities of $214.36 million in Q2 2026, up 574.9% from $31.76 million a year earlier.

Analysis

Rocket Pharmaceuticals (RCKT) Cash from Investing Activities (2015 - 2026) Analysis & Trends

On a TTM basis, Rocket Pharmaceuticals' Cash from Investing Activities came in at $361.85 million as of Jun 30, 2026; for FY2025, it was $103.77 million, down 21.2% from FY2024.

  • Across earlier years, Cash from Investing Activities came in at $131.71 million in FY2024, -$98.07 million in FY2023, -$69.33 million in FY2022 and $18.85 million in FY2021.
  • The Q2 2026 figure is the highest quarterly Cash from Investing Activities in data going back to Q2 2015.
  • On a year-over-year basis, Cash from Investing Activities rose in three of the last four quarters, with growth averaging 153.5%.
  • Peak year-over-year performance for Cash from Investing Activities in the last five years was growth of 574.9% in Q2 2026, against a decline of 60.4% in Q2 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $17.45 million (Q1 2026), $36.43 million (Q4 2025) and $93.62 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -1.11 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -2.91 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.35 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.11 Bn
10 Rocket Pharmaceuticals 280.42 Mn 280.42 Mn - 214.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 214.36 Mn
Mar 31, 2026 17.45 Mn
Dec 31, 2025 36.43 Mn
Sep 30, 2025 93.62 Mn
Jun 30, 2025 31.76 Mn
Mar 31, 2025 -58.04 Mn
Dec 31, 2024 -37.87 Mn
Sep 30, 2024 78.92 Mn
Jun 30, 2024 55.62 Mn
Mar 31, 2024 35.03 Mn
Dec 31, 2023 -140.81 Mn
Sep 30, 2023 48.25 Mn
Jun 30, 2023 31.21 Mn
Mar 31, 2023 -36.72 Mn
Dec 31, 2022 -108.59 Mn
Sep 30, 2022 23.47 Mn
Jun 30, 2022 78.79 Mn
Mar 31, 2022 -63.00 Mn
Dec 31, 2021 16.86 Mn
Sep 30, 2021 -18.19 Mn
API Access

Rocket Pharmaceuticals Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=RCKT&period=max&api_key=YOUR_API_KEY